Cite
Comparative Study of Intravenous Immunoglobulin and Leflunomide Combination Therapy With Intravenous Immunoglobulin Single Therapy in Kidney Transplant Patients With BK Virus Infection: Single-Center Clinical Trial.
MLA
Rasaei, Nakisa, et al. “Comparative Study of Intravenous Immunoglobulin and Leflunomide Combination Therapy With Intravenous Immunoglobulin Single Therapy in Kidney Transplant Patients With BK Virus Infection: Single-Center Clinical Trial.” Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation, vol. 21, no. 10, Oct. 2023, pp. 814–19. EBSCOhost, https://doi.org/10.6002/ect.2023.0071.
APA
Rasaei, N., Malekmakan, L., Gholamabbas, G., & Abdizadeh, P. (2023). Comparative Study of Intravenous Immunoglobulin and Leflunomide Combination Therapy With Intravenous Immunoglobulin Single Therapy in Kidney Transplant Patients With BK Virus Infection: Single-Center Clinical Trial. Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation, 21(10), 814–819. https://doi.org/10.6002/ect.2023.0071
Chicago
Rasaei, Nakisa, Leila Malekmakan, Ghazal Gholamabbas, and Pedram Abdizadeh. 2023. “Comparative Study of Intravenous Immunoglobulin and Leflunomide Combination Therapy With Intravenous Immunoglobulin Single Therapy in Kidney Transplant Patients With BK Virus Infection: Single-Center Clinical Trial.” Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation 21 (10): 814–19. doi:10.6002/ect.2023.0071.